Clinical study investigating the role of lymphadenectomy, surgical castration and adjuvant hormonal treatment in endometrial stromal sarcoma

British Journal of Cancer

Volumn 97, Issue 9, 2007, Pages 1194-1199

  Amant, F ^a   De Knijf, A ^a   Van Calster, B ^b   Leunen, K ^a   Neven, P ^a   Berteloot, P ^a   Vergote, I ^a   Van Huffel, S ^b   Moerman, P ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b Katholieke Universiteit Leuven   (Belgium)

Author keywords

Adenosarcoma; Endometrial; Hormonal; Lymphadenectomy; Sarcoma; Stromal

Indexed keywords

GESTAGEN; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE ACETATE;

ADJUVANT THERAPY; ADULT; ARTICLE; CANCER RECURRENCE; CANCER RELAPSE; CANCER STAGING; CASTRATION; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; ENDOMETRIUM SARCOMA; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HORMONAL THERAPY; HUMAN; HUMAN TISSUE; HYSTERECTOMY; KAPLAN MEIER METHOD; LUNG METASTASIS; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; LYMPHADENOPATHY; PREMENOPAUSE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SALPINGOOOPHORECTOMY;

ADOLESCENT; ADULT; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYSTERECTOMY; LYMPH NODE EXCISION; MEDROXYPROGESTERONE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SARCOMA, ENDOMETRIAL STROMAL; TREATMENT OUTCOME;

EID: 35649027850     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603986     Document Type: Article

References (26)

1. Amant F, Moerman P, Cadron I, Neven P, Berteloot P, Vergote I (2003) The diagnostic problem of endometrial stromal sarcoma: report on 6 cases. Gynecol Oncol 90: 37-43
2. Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I (2005) Endometrial cancer. Lancet 366: 491-505
3. Amant F, Moerman P, Vergote I (2004a) The classification of a uterine sarcoma as 'high-grade endometrial stromal sarcoma' should be abandoned. Gynecol Oncol 95: 412-413
4. Amant F, Schurmans K, Steenkiste E, Verbist L, Abeler V, Tulunay G, de Jonge E, Massuger L, Moerman P, Vergote I (2004b) Immunohistochemical determination of estrogen and progesterone receptor positivity in uterine adenosarcoma. Gynecol Oncol 93: 680-685
5. Beer TW, Buchanan R, Buckley CH (1995) Uterine stromal sarcoma following tamoxifen treatment. J Clin Pathol 48: 596
6. Burke C, Hickey K (2004) Treatment of endometrial stromal sarcoma with a gonadotropin-releasing hormone analogue. Obstet Gynecol 104: 1182-1184
7. Chang K, Crabtree G, Lim-Tan S, Kempson R, Hendrickson M (1990) Primary uterine endometrial stromal neoplasms. Am J Surg Pathol 14: 415-439
8. Chu M, Mor G, Lim C, Zheng W, Parkash V, Schwartz P (2003) Low-grade endometrial stromal sarcoma: hormonal aspects. Gynecol Oncol 90: 170-176
9. Clement P, Scully R (1974) Mullerian adenosarcoma of the uterus: a clinicopathologic analysis of ten cases of a distinctive type of Mullerian mixed tumor. Cancer 34: 1138-1149
10. Clement P, Scully R (1990) Mullerian adenosarcoma of the uterus: a clinicopathologic analysis of 100 cases with a review of the literature. Hum Pathol 21: 363-381
11. Evans H (1982) Endometrial stromal sarcoma and poorly differentiated endometrial sarcoma. Cancer 50: 2170-2182
12. Gadducci A, Sartori E, Landoni F, Zola P, Maggino T, Urgesi A, Lissoni A, Losa G, Fanucchi A (1996) Endometrial stromal sarcoma: analysis of treatment failures and survival. Gynecol Oncol 63: 247-253
13. Gloor E, Schnyder P, Cikes M, Hofstetter J, Cordy R, Burnier K (1982) Endolymphatic stromal myosis: surgical and hormonal treatment of extensive abdominal recurrence 20 years after hysterectomy. Cancer 50: 1888-1889
14. Hart W, Yoonnessi M (1977) Endometrial stromatosis of the uterus. Obstet Gynecol 49: 393-403
15. Kaplan E, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481
16. Leunen K, Amant F, Debiec-Rychter M, Croes R, Hagemeijer A, Schoenmakers E, Vergote I (2003) Endometrial stromal sarcoma presenting as postpartum haemorrhage: report of a case with a sole t(10;17)(q22;p13) translocation. Gynecol Oncol 91: 265-271
17. Leunen M, Breugelmans H, De Sutter Ph, Bourgain C, Amy JJ (2004) Low-grade endometrial stromal sarcoma treated with the aromatase inhibitor Letrozole. Gynecol Oncol 95: 769-771
18. Li A, Giuntoli R, Drake R, Byun S, Rojas F, Barbuto D, Klipfel N, Edmonds P, Miller D, Karlan B (2005) Ovarian preservation in stage I low-grade endometrial stromal sarcomas. Obstet Gynecol 106: 1304- 1308
19. Maluf F, Sabbatini P, Schwartz L, Xia F, Aghajanian C (2001) Endometrial stromal sarcoma: objective response to letrozole. Gynecol Oncol 82: 384-388
20. Newcombe RG (1998) Interval estimation for the difference between independent proportions: comparison of eleven methods. Stat Med 17: 873-890
21. Oliva E, Clement P, Young R (2000) Endometrial stromal tumors: an update on a group of tumors with a protean phenotype. Adv Anat Pathol 7: 257-281
22. Pink D, Lindner T, Mrozek A, Kretzschmar A, Thuss-Patience P, Dörken B, Reichardt P (2006) Harm or benefit of hormonal treatment in metastatic low-grade endometrial stromal sarcoma: single center experience with 10 cases and review of the literature. Gynecol Oncol 101: 464-469
23. Reich O, Regauer S, Urdl W, Lahousen M, Winter R (2000) Expression of oestrogen and progesterone receptors in low-grade endometrial stromal sarcomas. Br J Cancer 82: 1030-1034
24. Reich O, Winter R, Regauer S (2005) Should lymphadenectomy be performed in patients with endometrial stromal sarcoma? Gynecol Oncol 97: 982
25. Riopel J, Plante M, Renaud M, Roy M, Têtu B (2005) Lymph node metastases in low-grade endometrial stromal sarcoma. Gynecol Oncol 96: 402-406
26. Sterne JA, Davey Smith G (2001) Sifting the evidence - what's wrong with significance tests. BMJ 322: 226- 231